Related Articles
Combination therapy with cisplatin, 5'-deoxy-5-fluorouridine (5'-DFUR) and mitomycin (MMC) in patients with inoperable, advanced gastric cancer
Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer
Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma.
Bolus and infusional 5-fluorouracil combined with cisplatin in advanced gastric cancer.
Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status